Use of cepheid xpert carba-r® for rapid detection of carbapenemase-producing bacteria in abdominal septic patients admitted to intensive care unit

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Cortegiani, Andrea ^a   Russotto, Vincenzo ^a   Graziano, Giorgio ^a   Geraci, Daniela ^a   Saporito, Laura ^a   Cocorullo, Gianfranco ^a   Raineri, Santi Maurizio ^a   Mammina, Caterina ^a   Giarratano, Antonino ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; DIAGNOSTIC KIT;

ABDOMINAL DRAINAGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; NONHUMAN; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS; ABDOMEN; DIAGNOSTIC KIT; DRUG EFFECTS; ENTEROBACTERIACEAE; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; RECTUM;

ABDOMEN; AGED; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84983408935     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160643     Document Type: Article

References (24)

1. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical Microbiology and Infection 2012, 18(5):413-431. doi: 10.1111/j.1469-0691.2012.03821.x PMID: 22507109
2. Dinubile M, Friedland I, Chan C, Motyl M, Giezek H, Shivaprakash M, et al. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. European Journal of Clinical Microbiology and Infectious Diseases 2005, 24(7):443-449. PMID: 15990986
3. Di Carlo P, Vitale F, Ó'Súilleabháin C, Casuccio A. Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms. Current infectious disease reports 2014, 16(10):1-8.
4. Savard P, Perl T. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clinical Microbiology and Infection 2014, 20(9):854-861. doi: 10.1111/ 1469-0691.12748 PMID: 24980472
5. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock&z.ast;. Critical care medicine 2006, 34(6):1589-1596. PMID: 16625125
6. Eckmann C, Dryden M, Montravers P, Kozlov R, Sganga G. Antimicrobial Treatmdent of" Complicated" Intra-Abdominal Infections and The New IDSA Guidelines-A Commentary and an Alternative European Approach According to Clinical Definitions. European journal of medical research 2011, 16(3):115.PMID: 21486724
7. Herzog T, Chromik A, Uhl W. Treatment of complicated intra-abdominal infections in the era of multidrug resistant bacteria. European journal of medical research 2010, 15(12):525. PMID: 21163727
8. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program. Critical care medicine 2014, 42(8):1749-1755. doi: 10.1097/CCM.0000000000000330 PMID: 24717459
9. Zavascki AP, Bulitta JB, Landersdorfer CB. Combination therapy for carbapenem-resistant Gram-negative bacteria. 2013.
10. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clinical infectious diseases 2011, 53(1):60-67. doi: 10.1093/cid/cir202 PMID: 21653305
11. Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M. The era of molecular and other nonculture-based methods in diagnosis of sepsis. Clinical microbiology reviews 2010, 23(1):235-251. doi: 10.1128/CMR.00043-09 PMID: 20065332
12. Diekema DJ, Pfaller MA. Rapid detection of antibiotic resistant organism carriage for infection prevention. Clinical infectious diseases 2013:cit038.
13. Cortegiani A, Russotto V, Capuano P, Tricoli G, Geraci D, Ghodousi A, et al. Use of Cepheid Xpert Carba-R1 for rapid detection of carbapenemase-producing bacteria in critically ill, abdominal surgical patients: first report of an observational study. Critical Care 2015, 19(Suppl 1):P108.
14. Kim D-K, Kim HS, Pinto N, Jeon J, D'Souza R, Kim MS, et al. Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital. Annals of laboratory medicine 2016, 36(2):162-165. doi: 10.3343/alm.2016.36.2.162 PMID: 26709264
15. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive care medicine 2013, 39(2):165-228. doi: 10.1007/s00134-012-2769-8 PMID: 23361625
16. Matuschek E, Brown D, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clinical Microbiology and Infection 2014, 20(4):O255-O266. doi: 10.1111/1469-0691.12373 PMID: 24131428 17. [http://www.eucast.org/clinical-breakpoints/]
17. Bonura C, Giuffrè M, Aleo A, Fasciana T, Di Bernardo F, Stampone T, et al. An update of the evolving epidemic of bla KPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones. PloS one 2015, 10(7):e0132936. doi: 10.1371/journal.pone.0132936 PMID: 26177547
18. Mammina C, Palma DM, Bonura C, Aleo A, Fasciana T, Sodano C, et al. Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo, Italy. BMC research notes 2012, 5(1):365.
19. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 2010:dkp498.
20. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. International journal of antimicrobial agents 2006, 27(4):351-353. PMID: 16564159
21. Sahuquillo-Arce JM, Hernández-Cabezas A, Yarad-Awad F, Ibáñez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: a worldwide threat to antimicrobial therapy. 2014.
22. Aljohani S, Al Enizi T. Utility of Xpert Carba-R1 in diagnostic laboratory for early detection of carbapenems resistant Enterobacteriaceae. Antimicrobial Resistance and Infection Control 2015, 4(Suppl 1): P117.
23. Woodford N, Wareham DW, Guerra B, Teale C. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our ownmaking? Journal of Antimicrobial Chemotherapy 2014, 69(2):287-291. doi: 10.1093/jac/dkt392 PMID: 24092657
24. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. Journal of Antimicrobial Chemotherapy 2012, 67(7):1597-1606. doi: 10.1093/jac/dks121 PMID: 22499996